Protalix BioTherapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKBA
|
Akebia Therapeutics, Inc. | $1.87 | $222.17 M | -4.82 | 167 | $194.62 M |
 ALDX
|
Aldeyra Therapeutics, Inc. | $4.86 | $229.34 M | -7.57 | 9 | $0 |
 CDTX
|
Cidara Therapeutics, Inc. | $20.55 | $58.57 M | -1.59 | 69 | $63.91 M |
 CKPT
|
Checkpoint Therapeutics, Inc. | $3.74 | $68.32 M | -0.72 | 23 | $103,000 |
 CRVS
|
Corvus Pharmaceuticals, Inc. | $8.95 | $126.98 M | -3.98 | 28 | $0 |
 EFTR
|
eFFECTOR Therapeutics, Inc. | $0.00 | $6.16 M | -0.1 | 14 | $0 |
 ELEV
|
Elevation Oncology, Inc. | $0.61 | $192.87 M | -4.15 | 29 | $0 |
 GMDA
|
Gamida Cell Ltd. | $0.03 | $4.34 M | -0.04 | 143 | $1.78 M |
 IMGN
|
ImmunoGen, Inc. | $31.24 | $8.73 B | -111.55 | 277 | $108.78 M |
 IOVA
|
Iovance Biotherapeutics, Inc. | $8.55 | $2.18 B | -4.3 | 557 | $1.19 M |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 LXRX
|
Lexicon Pharmaceuticals, Inc. | $0.86 | $632.61 M | -2.11 | 285 | $1.20 M |
 MCRB
|
Seres Therapeutics, Inc. | $0.77 | $92.99 M | -1.04 | 233 | $126.33 M |
 PDSB
|
PDS Biotechnology Corporation | $2.10 | $106.92 M | -2.13 | 25 | $0 |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.34 | $169.62 M | -1.51 | 127 | $0 |